Clinical Trial Update: Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of a semaglutide protocol on physical health measures in patients treated with atypical antipsychotics; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Psychiatric Disorders

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: St Andrew's Healthcare | Conditions: Obesity and Obesity-related Medical Conditions, Psychiatric Disorders | Phase 4 | Status: RECRUITING